Riskpilot← Back to searchSign inGet full accessFELIX HOLDING AS
ASActiveOrg 988829269Stollen 40, 3030 DrammenRetail sale of pharmaceutical products · NACE 4773Est. 20051 employees
Revenue 2024
NOK 1,2M
+21% vs 2023
EBITDA margin
70.0%
+28% vs 2023
Equity ratio
98.5%
Financial strength
Net profit 2024
NOK 4M
+81% vs 2023
| Revenue | NOK 1,2M | +21% |
| EBITDA | NOK 840K | +28% |
| Net profit | NOK 4M | +81% |
| Total assets | NOK 37,7M | +12% |
| Equity | NOK 37,1M | +12% |
| Employees | 1 | — |
Legal name
FELIX HOLDING AS
Org number
988829269
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
5. november 2005
Share capital
NOK 900 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Investeringer i apotek, konsulentvirksomhet og tjenestesalg innen apotekbransjen og i tilknytning til legemiddel- og helserelaterte produkter, samt annet som står i forbindelse med dette herunder deltakelse i andre virksomheter.
Address
Stollen 40, 3030 Drammen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 703 | 960 | 960 | 990 | 1 200 |
| Staff expenses | −332 | −329 | −330 | −27 | −15 |
| EBITDA | 1 250 | 506 | 471 | 655 | 840 |
| Depreciation & amort. | −93 | −0 | −0 | −120 | −181 |
| EBIT | 1 157 | 506 | 471 | 535 | 659 |
| Net financials | 2 807 | 1 432 | 1 026 | 1 927 | 3 709 |
| Profit before tax | 3 964 | 1 938 | 1 497 | 2 462 | 4 368 |
| Tax | 320 | 151 | 172 | 227 | 327 |
| Net profit | 3 644 | 1 786 | 1 326 | 2 234 | 4 041 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 38 516 | 30 387 | 31 794 | 33 766 | 37 682 |
| Equity | 34 080 | 29 867 | 30 903 | 33 121 | 37 102 |
| Long-term debt | 6 | 5 | 4 | 18 | 22 |
| Short-term debt | 4 430 | 516 | 886 | 627 | 559 |
| Total debt | 4 436 | 521 | 890 | 645 | 581 |
EBITDA margin
70.0%
This company
15.8%
Market median
+343% vs market
20202024
Equity ratio
98.5%
This company
38.2%
Market median
+158% vs market
20202024
Return on equity
10.9%
This company
18.4%
Market median
+41% vs market
20202024
Net profit margin
336.8%
This company
8.1%
Market median
+4058% vs market
20202024
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20202024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KH Deputy Member | Deputy Member | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
FELIX HOLDING AS 
FELIX FARMASI ASBoard members of FELIX HOLDING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kirsti Hjelle | Deputy Member | 0 companies |
| Felix Kamal Ally | Chairman | 0 companies |